odronextamab
regeneron
['love this', '$regn']
don't love this drug, granted this trial is mostly 3rd line use if i followed correctly but still a tough efficacy/tox profile #odrontextamab
$regn
#ash22
Co-founder, President & CSO, Aleta Biotherapeutics, https://t.co/vyLXDleOdp -  Founder & Principal, SugarCone Biotech, commentary at https://t.co/nE18E8qx8B